The role of pharmacogenetics in the new ESMO colorectal cancer guidelines

Pharmacogenomics. 2017 Feb;18(3):197-200. doi: 10.2217/pgs-2016-0191. Epub 2017 Jan 23.
No abstract available

Keywords: DPD; ERCC1; UGT; colorectal cancer; pharmacogenetic.

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor / genetics
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / genetics*
  • Humans
  • Pharmacogenetics / methods
  • Polymorphism, Single Nucleotide / genetics

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor